ASX:AYA

Artrya (AYA) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free AYA Stock Alerts

Compare

Today's Range: N/A
50-Day Range: N/A
52-Week Range: N/A

Volume: N/A
Average Volume: N/A
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Artrya alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Artrya

Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

AYA Stock News Headlines

April 3, 2024 | finance.yahoo.com

Is Artrya (ASX:AYA) In A Good Position To Deliver On Growth Plans?

February 18, 2024 | msn.com

Compare with Artrya Ltd (AYA)

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

January 3, 2024 | finance.yahoo.com

Artrya Limited (AYA.AX)

November 17, 2023 | npr.org

Aya Batrawy

November 3, 2023 | finance.yahoo.com

Favourable Signals For Artrya: Numerous Insiders Acquired Stock

August 6, 2022 | finance.yahoo.com

We're Not Very Worried About Artrya's (ASX:AYA) Cash Burn Rate

August 1, 2022 | proactiveinvestors.com

Artrya appoints US healthcare leader as non-executive director

April 20, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

June 27, 2022 | proactiveinvestors.com.au

A theatre of human innovation

June 27, 2022 | finance.yahoo.com

ARTRYA APPOINTS RENOWNED EXECUTIVE DR JACQUE SOKOLOV AS UNITED STATES ADVISOR

June 27, 2022 | finance.yahoo.com

Artrya (ASX:AYA) Is In A Good Position To Deliver On Growth Plans

See More Headlines

Receive AYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Artrya and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: ASX
Sector: Medical
Industry: Health Information Services
Sub-Industry: N/A
Current Symbol: ASX:AYA
CUSIP: N/A
CIK: N/A
Web: www.artrya.com
Phone: 61 8 6478 7816
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): A($0.15)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-11,560,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -39.26%
Return on Assets: -23.41%

Debt

Debt-to-Equity Ratio: 4.54
Current Ratio: 11.54
Quick Ratio: 18.20

Sales & Book Value

Annual Sales: $197,000.00
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: A$0.30 per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 78,650,000
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.75

A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Mathew Regan
Chief Executive Officer
Mr. John Konstantopoulos B.E.
Co-Founder and Executive of Commercial & Strategy
Mr. Mark Wainwright
Chief Financial Officer
Prof. Girish Dwivedi M.D.
Chief Scientific Officer
Mr. Ted Schwab
Co-CEO of Artrya USA Inc
Mr. Kevin Ronald Hart B.Com. (Age 62)
B.Comm (Hons), C.A., F.C.A., Company Secretary

Key Competitors

View All Competitors

Insiders

This page (ASX:AYA) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Artrya (AYA) Stock Price, News & Analysis

About Artrya

AYA Stock News Headlines

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info